Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
India Proposes Central Regulatory Oversight for Antimicrobials to Address Resistance

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Politics

India Proposes Central Regulatory Oversight for Antimicrobials to Address Resistance

Analysed 19 Nov 2026·4 sources analysed·New Delhi, India·Politics
India Proposes Central Regulatory Oversight for Antimicrobials to Address ResistancePreviousNext

The Indian Health Ministry has proposed amending the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials—including antibiotics, antivirals, and antifungals—under central regulatory oversight. This change would require manufacturers to obtain prior approval from the Central Licensing Authority before state licensing, ensuring stricter scrutiny of quality, safety, efficacy, and bioequivalence. The move aims to address concerns over antimicrobial resistance by preventing substandard products and strengthening regulatory controls, with public feedback invited before finalization.

Sentiment
60%
TBN's observations

First-hand measurement across 4 sources

We measured how 4 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (60/100). Lens Score 55/100.

Outlets measured: businessstandard, economictimes, deccanherald, hindustantimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 4 sources · Published under editorial oversight by The Balanced News
Analysed 19 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (60/100)

Sentiment was consistent across outlets (52–65/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

hindustantimes broke this story on 19 Nov, 07:03 am. Other outlets followed.

19 Nov, 07:03 am4 sources · 2 h19 Nov, 09:14 am
AI analysis by the TBN Bias Engine · beat methodology byPrajakta Kale· Political Analyst· editorial standards byOjas Kale
← Previous
US, Russia, and China Hold Trilateral Summit in Shenzhen to Discuss Global Challenges
Next →
Kerala Left Front Divided Over PM SHRI Scheme Signing and Opposition
  1. 1
    hindustantimes19 Nov, 07:03 am
    Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight
  2. 2
    deccanherald19 Nov, 07:28 am
    Antimicrobial drugs: Centre proposes strict rules to curb resistance
  3. 3
    economictimes19 Nov, 08:05 am
    Centre proposes tighter regulatory oversight of antimicrobials to tackle drug resistance
  4. 4
    businessstandard19 Nov, 09:14 am
    Centre proposes central approval for antimicrobials amid AMR concerns

Who's involved

Institutions and figures named across source coverage.

Government
State Licensing AuthorityCentral Licensing AuthorityMinistry of Health and Family Welfare

Story context

Category
Politics
Location
New Delhi, India
Sources analysed
4
Last analysed
19 Nov 2026
Key entities
AntimicrobialEfficacyBioavailabilityInfectionAntimicrobial resistanceMinistry of Health and Family WelfareGlobal healthPatient safetyMicroorganismSkinNew DelhiOne Health